Emma Brofsky, M.S.P.H.

Emma Brofsky is a Scientific Program Analyst in the Division of Cancer Prevention at the National Cancer Institute. She serves as Project Manager for two research networks, the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet), focused on collaborations to evaluate approaches for prevention of HPV-related cancers in people living with HIV, and the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network, focused on pragmatic clinical trials on optimizing the cervical cancer screening, management, and precancer treatment cascade for women with HIV. In addition, she supports other projects within the Breast and Gynecological Cancer Research Group and the Division.

Emma received a B.S. in Biological Sciences from Cornell University and a Master of Science in Public Health in Global Disease Epidemiology and Control from the Johns Hopkins Bloomberg School of Public Health. She has experience working with local, state, and federal public health agencies as well as in international field settings on projects related to emerging infectious disease response, program implementation, and maternal and child health.